http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-405276-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-20
filingDate 1972-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1975-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-405276-A1
titleOfInvention A PROCEDURE TO PRODUCE 1- (4-METHYL-6-HYDROXY-2-PIRI-MIDINYL) -3-METHYL-PIRAZOLINE-5-ONA.
abstract A intermediate, 1-(4-methyl-6-hydroxy-2-pyrimidinyl)-3-methylpyrazoline-5-one, is produced by reacting aminoguanidine or one of its salts with acetoacetamide, and then reacting the product with an alkyl acetoacetate in the presence of a basic catalyst. The intermediate is useful for producing 1-(4-methyl-6-methoxy-2-pyrimidinyl)-3-methyl-5-methoxypyrazole which has been employed clinically as an excellent anti-inflammatory drug.
priorityDate 1971-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135464837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426030659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2146

Total number of triples: 19.